Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial

BACKGROUND: Recently, a few studies based on anti-factor Xa activity levels have propounded doubtful and sub-prophylactic levels by the usual dose of enoxaparin in surgical and critically ill patients. In this study, we assessed two doses of enoxaparin in adult non-critically ill patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavi-Darazam, Ilad, Forouhar, Kimia, Moradi, Omid, Saffaei, Ali, Asadi, Sara, Sahraei, Zahra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Briefland 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024325/
https://www.ncbi.nlm.nih.gov/pubmed/36942062
http://dx.doi.org/10.5812/ijpr-126555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024325/
https://www.ncbi.nlm.nih.gov/pubmed/36942062
http://dx.doi.org/10.5812/ijpr-126555

Ejemplares similares